Recruiting Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial NCT07167329 Conditions Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +44 more Locations AC Camargo Cancer Center — São Paulo, Brazil View Trial Details
Completed Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 Conditions Acoustic Neuroma, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +61 more Locations Yale New Haven Hospital — New Haven, Connecticut, United States Massachusetts General Hospital — Boston, Massachusetts, United States Brigham & Women's Hospital — Boston, Massachusetts, United States University of Missouri — Columbia, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Phase II Study of Vandetanib in Individuals With Kidney Cancer NCT00566995 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
